We advised B. Braun on the sale of Ortopedicum to the LUX MED Group

B. Braun is a world leader in medical technology. An innovator and active promoter of progress, it has been creating and setting global standards in healthcare for more than 180 years. With a presence in 64 countries and more than 63,000 employees, the company today offers more than 5,000 healthcare products.

B. Braun, in focusing on the further development of its product sales, decided to sell the company Ortopedicum, which owns a specialist orthopaedic hospital in Krakow. And we advised them on this transaction.


An important step in the professionalisation of the Polish medical services market

The Ortopedicum sale project was led by Paweł Mardas, Partner and Head of the M&A Practice, and Adam Czarnota, Senior Associate in the Corporate Practice.

Our advice included structuring the transaction, drafting and negotiating transaction documentation and coordinating the entire process of selling the company.

The transaction was very important for both parties, says Paweł Mardas.

B. Braun remains focused on its core business areas of manufacturing and distributing highly specialised medical products. The hospital services provided by Ortopedicum were a side business. For LUX MED, on the other hand, the acquisition of Ortopedicum is another important step in its market strategy, adds the head of our M&A practice.

LUX MED changes the Polish healthcare market

LUX MED has acquired 100% of the shares in Ortopedicum, adding another – the sixteenth – hospital to its portfolio.

I am extremely pleased to announce that the renowned Ortopedicum hospital in Kraków is joining the LUX MED Group! I believe that if you want to change the healthcare market in Poland, you have to be ready to make bold decisions and investments, and the acquisition of the Ortopedicum hospital – a modern orthopaedic and rehabilitation centre – is undoubtedly one of these, said Anna Rulkiewicz, President of the LUX MED Group.

The buyer was represented by the Gessel law firm.

Any questions? Contact us

Paweł Mardas

Adam Czarnota


Contact us: